Premium
Serum copper in ovarian carcinoma
Author(s) -
Jacobs Allan J.,
Sommers Gara M.,
Axelrod Janice H.,
Galakatos Andrew E.,
Kao MingShian,
Camel H. Marvin
Publication year - 1988
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19880301)61:5<1015::aid-cncr2820610526>3.0.co;2-t
Subject(s) - ovarian carcinoma , medicine , copper , epithelial ovarian carcinoma , carcinoma , serum concentration , malignancy , ovary , gastroenterology , ovarian cancer , pathology , cancer , chemistry , organic chemistry
Abstract The serum copper and CA 125 levels of 31 patients with epithelial ovarian carcinoma were determined. Serum copper was elevated in seven patients and CA 125 was elevated in 22 patients. A rise in serum CA 125 always was associated with disease progression. In comparison, serum copper fluctuation did not correlate with the natural history of the malignancy. We concluded that serum copper determination has no use in epithelial ovarian carcinoma management.